Clinical Trials Logo

Clinical Trial Summary

Purpose: We determined the incidence, etiology, and longitudinal trends of vitreoretinal diseases necessitating pars plana vitrectomy (PPV) in the pediatric and adolescent population. Design: This was a nationwide, population-based cohort study, utilizing data from the Korean National Health Claims database spanning from 2009 to 2020. Given the retrospective design of the study and the anonymized nature of the data, the requirement for informed consent was waived. Methods: All pediatric and adolescent patients (under 20 years of age) who underwent PPV across the Korean population were included. The cumulative incidence of PPV was estimated from 2009 to 2020, with 2009 to 2011 as the washout period. The annual trends of PPV incidence, the proportion of each etiology, and comorbidity were estimated based on sex and specific age groups.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06123923
Study type Observational
Source Seoul National University Hospital
Contact
Status Completed
Phase
Start date October 16, 2022
Completion date October 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT00744666 - IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Phase 4
Completed NCT02477605 - Clinical Comparison of 27+® and 23-gauge ULTRAVIT® 7500 Cpm Vitrectomy Outcomes N/A
Recruiting NCT06429969 - Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.
Recruiting NCT06294613 - A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases N/A